期刊文献+

胆系恶性肿瘤p16,PTEN和nm23基因的表达及其临床意义 被引量:4

Study on clinical significance of expression of p16,nm23 and PTEN gene in malignant tumors of biliary system
暂未订购
导出
摘要 目的探讨胆系恶性肿瘤组织中p 1 6,nm 2 3和PTEN基因蛋白表达的临床意义。方法利用SP免疫组化方法检测6 3例胆系恶性肿瘤(胆管腺癌3 3例,胆囊腺癌3 0例)和2 0例胆管良性病变组织中p 1 6,PTEN和nm 2 3基因蛋白的阳性表达情况,结合临床病理资料进行分析。结果p 1 6,nm 2 3及PTEN 3种基因蛋白在胆道腺癌组织中呈低-中度阳性表达,其阳性表达率分别为36.5%,3 8.1%,2 3.8%,明显低于胆管良性病变组,差异有统计学意义(P<0.0 5)。PTEN在高分化胆管腺癌与胆囊腺癌表达有明显差异(P<0.0 5),而p 1 6和nm 2 3差异不明显。结论胆系恶性肿瘤中存在上述3种基因变异或缺失。PTEN和p 1 6基因变异对细胞周期均失去调控,从而促进肿瘤生长,PTEN和nm 2 3基因的变异降低了对胆系肿瘤浸润转移的制约。 Objective To study the clinical significance of the gene protein expression of p16, nm23 and PTEN in bile duct carcinoma. Methods The expression of p16, PTEN and nm23 gene protein in tissues of 63 cases of malignant tumors of biliary system ( 33 cases of bile duct carcinoma, 30 cases of carcinoma of gallbladder ) and 20 cases of benign bile duct lesion were studied by SP immunohistochemical technique and analyzed together with clinicopathologic data. Results The positive expression of p 16, PTEN and nm23 in bile duct carcinoma tissue was low to medium, their expression rate was 36. 5 % , 38. 1% and 23. 8% , respectively, and was significantly lower than that of bile duct benign lesions (P 〈 0. 05 ). In the well-differentrated bile duct carcinoma and gallbladder carcinoma group, the expression of PTEN was significantly different( P 〈 0. 05 ), but p16, PTEN and nm23 expression was not significantly different. Conclusions Mutation or deletion of the above 3 genes is present in malignant tumors of biliary system. PTEN and p 16 gene mutation can loss control of the cell cycle and thus promote tumor development. PTEN and nm23 gene mutation can lower the controlability of invasiveness and metastasis of tumors of biliary system.
出处 《中国普通外科杂志》 CAS CSCD 2006年第3期195-197,共3页 China Journal of General Surgery
关键词 胆道肿瘤 病理学 基因表达 癌基因蛋白类 Bilary Tract Neoplasms/pathol Gene Expression Oncogene Proteins
  • 相关文献

参考文献3

二级参考文献13

  • 1[1]Steck P A, Pershouse M A, Jasser S A, et al. Identification of candidate tumour suppressor gene, MMAC1, at chro-mosome 10q23.3 that is mutated in multiple advanced cancer [J]. Nat Genet, 1997,15:356-358.
  • 2[2]Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyro-sine phosphatase gene mutated in humian brain, breast, and prostate cancer [J]. Science, 1997,275:1 943-1 948.
  • 3[3]Myers M P, Stolarov P, Eng C. PTEN, the tumor suppressor from human 10q23,is a dual specificity phos-phatase [J]. Proc Natl Acad Sci USA, 1997,94:9 052-9 055.
  • 4[4]Maehama T, Dixon J E. The tumor supperssor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate [J]. J Biol Chem, 1998,273:13 375-13 379.
  • 5[5]Li J, Simpson L, Takaheshi M, et al. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene [J]. Cancer Res, 1998,58:5 667-5 669.
  • 6[6]Furnari F B, Lin H, Huang H S, et al. Growth suppression of gliona cells by PTEN requires a functional phosphatase caralytic domnin [J]. Proc Natl Acad Sci USA. 1997,94:1 247-1 249.
  • 7[7]Myers M P, Pass I, Barry I H, et al. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function [J]. Proc Natl Acad Sci USA, 1998,95:1 351-1 353.
  • 8Oka H,Shiozaki H,Kobayashi K,et al.Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasisCancer Research,1993.
  • 9Tamura M;Gu J;Matsumoto K.Inhibition of cell migration,spreading,and focal adhesions by tumor suppressor PTEN[J],1998(5369).
  • 10Yoshida H;Kijima H;Terasaki Y.Heterogenous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer,1998(06).

共引文献17

同被引文献36

  • 1刘民锋,徐立宁,左石,罗剑,郭伟,董泾青,邹声泉.体外转染PTEN抑制胆管癌QBC939细胞生长及下调mTOR表达的研究[J].中国普通外科杂志,2006,15(3):181-184. 被引量:2
  • 2刘民锋,罗剑,余险峰,唐启彬,陈勇军,邹声泉.PTEN和mTOR信号转导通路在胆管癌发展中作用的研究[J].中国普通外科杂志,2006,15(4):274-276. 被引量:13
  • 3Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate turnout suppressor gene, MMAC 1 at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997,15 (40) :356 - 362.
  • 4Wang SI, Parsons R, htmann M, et al, Homozygous deletion of PTEN tumor suppressor gene in a subset of prostate adenocarcinoma[J]. Clin Cancer Res,1998,4(6) :811 - 815.
  • 5L J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer [ J ]. Science, 1997,275 ( 5308 ) : 1943 - 1947.
  • 6Wang YE, Wu X, Suzuki H, et al. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate caner through loss of expression[J]. Proc Nail Acad Sci USA,1998,95(26) :5246 -5250.
  • 7Okami K,Wu L. Alterations in Riggins G,aerodigestive tract tumors [J]. Cancer Res,1998,58(3) :9 -511.
  • 8Parker SL, Tong T, Bolden S, et al. Cancer statistics [ J ] . CA Cancer J Clin, 1996, 46(1) :5 -27.
  • 9Blechacz BR, Gores GJ. Cholangiocarcinoma [ J ]. Clin Liver Dis, 2008, 12(1) :131 -150.
  • 10Siqueira E, Schoen RE, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis [ J]. Gastrointest Endosc, 2002, 56( 1 ) : 40 -47.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部